1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Digital Health Summer Summit 2013

Digital Health Summer Summit 2013

  • August 2013
  • -
  • Frost & Sullivan
  • -
  • 10 pages

Introduction

In a year of even more insanity in terms of the number of conferences attempting to show value in digital/connected health, we returned this year to the Digital Health Summer Summit (DHSS13) in San Diego, California. An attendee at the summit joked that the conference producers were the only people making money in this area. That, while not totally the case, shows the pressing desire of vendors and stakeholders to drive forward with more substantial, scalable, and sustainable business models in the space. While last year’s event seemed to have one too many wellness program/portal startups, at least for me, this one had a different mix of sessions. While there were many corporate sponsors of this summer’s event, the leading ones were UnitedHealthGroup, Welldoc, and Life Technologies.

Welldoc, BlueStar, and Ford

One unintentional theme of DHSS13 was centric to Welldoc, starting with the opening keynote by Welldoc President and COO, Dr. Anand Iyer. An important point discussed at the conference was that it happened to coincide with the announcement of BlueStar—a new Welldoc mHealth product which is both prescribed and reimbursable as part of diabetes therapy. BlueStar (http://www.bluestardiabetes.com/) provides support for diabetes patients in terms of motivational and behavioral coaching, as well as aspects including smart glucose blood testing and adherence support. This product was cleared by the FDA, for adults with Type 2 diabetes. It is directly accessible across various form factor platforms, including one that most companies are not able to tout—a Ford car.
This positive step in mHealth is the first of its kind in prescribed, reimbursed mHealth applications and a key highlight in the area in H1, 2013. As we seek to expand reimbursement for mHealth solutions and other offerings centric on remote medical care, these wins can be leveraged by other developers walking the same path. There is still a long road to go in drawing consumers out of the realm of ‘everything related to healthcare is an entitlement’. A push from self-insured employers can help to increase the threshold for this overall in the United States and set a good precedent for national reimbursement for specific applications. We cannot rely on leadership in general from Congress, or the FDA for what is needed to push the digital health space forward. Such leadership and creativity in approach, as shown by WellDoc, is overall a very positive example.

Ford Demo

The surprise part of the BlueStar announcement at the conference was a live demo with Ford, in front of the Omni hotel with a new Explorer, against the backdrop of Ford’s marketing of the Explorer as “Digital Health on Wheels”. It was entertaining to see the dash-embedded BlueStar link interacting with a “potential diabetes patient using the system in transit”. As part of this demo, I also got a free wine accessory kit, courtesy of Welldoc. It was a good show overall by them at the Digital Health Summer Summit.

Table Of Contents

Digital Health Summer Summit 2013
Introduction
Welldoc, BlueStar, and Ford
Ford Demo
Further Points of Interest from DHSS1
John Sculley and “His Angels”: Misfit Wearables, MD Live, WaterMark Medical
Our Health Ministry
Check Out These Links as Well
What to Avoid as a Smartphone Zombie
Keep it in Drive
Appendix
Legal Disclaimer
The Frost and Sullivan Story

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...

Global Markets for Diabetes Therapeutics and Diagnostics

Global Markets for Diabetes Therapeutics and Diagnostics

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Analyze the market for drugs used in the treatment of diabetes, it's technology and the industry as a whole - Identify important trends and provide sales forecasts by product categories ...

Personal Mobility Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

Personal Mobility Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

  • $ 5795
  • Industry report
  • August 2016
  • by Transparency Market Research

Personal mobility devices such as wheelchairs, mobility scooters, and stair lifts have witnessed significant growth in revenue and volume in the past few years. A personal mobility device is either a manual ...


ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.